RMTI: Strobeck Mark discloses a sale

By AlphaYouPublished Oct 5, 2026Form 4

Stocks in this disclosure

Reported activity

Strobeck Mark

Reporting filer

Strobeck Mark reported Sale in ROCKWELL MEDICAL, INC.: 1000 units of Common Stock, dated 2026-10-01. The full Form 4 contains 1 transaction entry.

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Common Stock	Strobeck Mark	2026-10-01	S	Sale	1000	8.42	61,349	4 days	Filed terms security Title: Common Stock transaction Date: 2026-10-01 transaction Form Type: 4 transaction Code: S equity Swap Involved: 0 id: F1 transaction Shares: 1000 transaction Price Per Share: 8.42 transaction Acquired Disposed Code: D shares Owned Following Transaction: 61349 direct Or Indirect Ownership: D

Owner: Strobeck Mark
Date: 2026-10-01
Code: S
Action: Sale
Quantity: 1000
Price: 8.42
Following holdings: 61,349
Reporting delay: 4 days
Filed terms and references: Filed terms
security Title: Common Stock
transaction Date: 2026-10-01
transaction Form Type: 4
transaction Code: S
equity Swap Involved: 0
id: F1
transaction Shares: 1000
transaction Price Per Share: 8.42
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 61349
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Strobeck Mark: President and CEO, Director.
The filing reports a Rule 10b5-1 trading plan.
F1: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2026.

Prepared automatically from public filing data. Report a correction.